<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39442753</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1943-7811</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>21</Day></PubDate></JournalIssue><Title>The Journal of molecular diagnostics : JMD</Title><ISOAbbreviation>J Mol Diagn</ISOAbbreviation></Journal><ArticleTitle>Considerations for SARS-CoV-2 Genomic Surveillance: A Joint Consensus Recommendation of the Association for Molecular Pathology and Association of Public Health Laboratories.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S1525-1578(24)00249-6</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jmoldx.2024.09.005</ELocationID><Abstract><AbstractText>Next-generation sequencing (NGS) has applications in research, epidemiology, oncology, and infectious disease diagnostics. Wide variability exists in NGS wet laboratory techniques and dry laboratory analytical considerations. Thus, many questions remain unanswered when NGS methods are implemented in laboratories for infectious disease testing. While this review is not intended to answer all questions, the most pressing questions from a public health and clinical hospital-based laboratory perspective will be addressed. The authors of this review are laboratory professionals who perform and interpret SARS-CoV-2 NGS results. Considerations for pre-analytical, analytical, and post-analytical NGS will be explored. This review highlights challenges for molecular laboratory professionals considering adopting or expanding NGS methods.</AbstractText><CopyrightInformation>Copyright Â© 2024. Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hirschhorn</LastName><ForeName>Julie W</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>The SARS-CoV-2 Whole Genome Sequencing Working Group of the Association for Molecular Pathology*, Rockville, MD; Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC; Diagnostic Medicine Institute, Geisinger, Danville, PA and Geisinger Commonwealth School of Medicine, Scranton, PA. Electronic address: jhirschhorn@geisinger.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Babady</LastName><ForeName>N Esther</ForeName><Initials>NE</Initials><AffiliationInfo><Affiliation>The SARS-CoV-2 Whole Genome Sequencing Working Group of the Association for Molecular Pathology*, Rockville, MD; Department of Pathology and Laboratory Medicine and Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bateman</LastName><ForeName>Allen</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>The SARS-CoV-2 Whole Genome Sequencing Working Group of the Association for Molecular Pathology*, Rockville, MD; Wisconsin State Laboratory of Hygiene, Madison, WI.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blankenship</LastName><ForeName>Heather M</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>The SARS-CoV-2 Whole Genome Sequencing Working Group of the Association for Molecular Pathology*, Rockville, MD; Division of Infectious Disease, Genomics Section, Michigan Department of Health and Human Services, Lansing, MI.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bard</LastName><ForeName>Jennifer Dien</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>The SARS-CoV-2 Whole Genome Sequencing Working Group of the Association for Molecular Pathology*, Rockville, MD; Pathology and Laboratory Medicine, Children's Hospital Los Angeles; Keck School of Medicine, University of Southern California, Los Angeles, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Florek</LastName><ForeName>Kelsey</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>The SARS-CoV-2 Whole Genome Sequencing Working Group of the Association for Molecular Pathology*, Rockville, MD; Wisconsin State Laboratory of Hygiene, Madison, WI.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Larkin</LastName><ForeName>Paige M K</ForeName><Initials>PMK</Initials><AffiliationInfo><Affiliation>The SARS-CoV-2 Whole Genome Sequencing Working Group of the Association for Molecular Pathology*, Rockville, MD; Department of Pathology, NorthShore University HealthSystem, Evanston, IL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rowlinson</LastName><ForeName>Marie-Claire</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>The SARS-CoV-2 Whole Genome Sequencing Working Group of the Association for Molecular Pathology*, Rockville, MD; Wadsworth Center Bacterial Diseases Laboratory, New York State Department of Health, Albany, NY; Bureau of Public Health Laboratories, Florida Department of Health, Jacksonville, FL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wroblewski</LastName><ForeName>Kelly</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>The SARS-CoV-2 Whole Genome Sequencing Working Group of the Association for Molecular Pathology*, Rockville, MD; Association of Public Health Laboratories, Silver Spring, MD.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wolk</LastName><ForeName>Donna M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>The SARS-CoV-2 Whole Genome Sequencing Working Group of the Association for Molecular Pathology*, Rockville, MD; Diagnostic Medicine Institute, Geisinger, Danville, PA and Geisinger Commonwealth School of Medicine, Scranton, PA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Mol Diagn</MedlineTA><NlmUniqueID>100893612</NlmUniqueID><ISSNLinking>1525-1578</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Clinical Laboratory</Keyword><Keyword MajorTopicYN="N">Next Generation Sequencing</Keyword><Keyword MajorTopicYN="N">Public Health Laboratory</Keyword><Keyword MajorTopicYN="N">Whole Genome Sequencing</Keyword><Keyword MajorTopicYN="N">molecular methods</Keyword><Keyword MajorTopicYN="N">surveillance</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>24</Day><Hour>0</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>24</Day><Hour>0</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>23</Day><Hour>19</Hour><Minute>24</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39442753</ArticleId><ArticleId IdType="doi">10.1016/j.jmoldx.2024.09.005</ArticleId><ArticleId IdType="pii">S1525-1578(24)00249-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle>